发展中国家对生物医学技术和植物生物技术的反应：突尼斯的经验
The Developing Country Reactions to Biomedical Techniques and Plant Biotechnology: The Tunisian Experience.
作者信息
Tebourski Fethi, Ben Ammar-Elgaaied Amel
出版信息
J Biomed Biotechnol. 2004;2004(3):124-129. doi: 10.1155/S1110724304401053.
Abstract
In the present study we present the conditions offered to biotechnology development in Tunisia and we compare three main biotechnology applications which raise ethical and health problems: organ transplant, assisted reproductive techniques, and genetically modified organisms. We try to identify factors that have allowed success of the first two applications and failure of the latter. Conditions offered to biotechnology in other African countries are also discussed.
摘要
在本研究中，我们介绍了突尼斯生物技术发展所具备的条件，并比较了引发伦理和健康问题的三种主要生物技术应用：器官移植、辅助生殖技术以及转基因生物。我们试图找出使前两种应用获得成功而后者失败的因素。同时也讨论了其他非洲国家的生物技术发展条件。
相似文献
1
The Developing Country Reactions to Biomedical Techniques and Plant Biotechnology: The Tunisian Experience.
J Biomed Biotechnol. 2004;2004(3):124-129. doi: 10.1155/S1110724304401053.
2
Case studies on the use of biotechnologies and on biosafety provisions in four African countries.
J Biotechnol. 2011 Dec 20;156(4):370-81. doi: 10.1016/j.jbiotec.2011.06.036. Epub 2011 Jul 6.
3
Ethical review of health-related biotechnology research in Africa: a role for the Pan African Bioethics Initiative (PABIN).
Afr J Med Med Sci. 2007;36 Suppl:43-7.
4
Animal biotechnology: applications and economic implications in developing countries.
Rev Sci Tech. 2005 Apr;24(1):127-39.
5
Ethics, biotechnology, and global health: the development of vaccines in transgenic plants.
Am J Bioeth. 2006 Jul-Aug;6(4):W29-41. doi: 10.1080/15265160600843551.
6
A functional abc for biotechnology and the dissemination of its progeny.
Stud Hist Philos Biol Biomed Sci. 2011 Jun;42(2):261-9. doi: 10.1016/j.shpsc.2010.12.008. Epub 2011 Feb 5.
7
From the tumor-inducing principle to plant biotechnology and its importance for society.
Int J Dev Biol. 2013;57(6-8):453-60. doi: 10.1387/ijdb.130295ga.
8
Moral questions, legal answers, and biotechnological advances.
Law Rev. 1998 Mar;28(1):225-42.
9
Plant biotechnology in China.
Science. 2002 Jan 25;295(5555):674-6. doi: 10.1126/science.1067226.
10
Policy and ethical issues in applying medical biotechnology in developing countries.
Med Sci Monit. 2003 Feb;9(2):RA49-54.
引用本文的文献
1
Human embryonic stem cell science and policy: the case of Iran.
Soc Sci Med. 2013 Dec;98(100):345-50. doi: 10.1016/j.socscimed.2013.10.028. Epub 2013 Nov 1.
2
Ethical aspects of human embryonic stem cell research in the islamic world: positions and reflections.
Stem Cell Rev Rep. 2010 Jun;6(2):151-61. doi: 10.1007/s12015-010-9117-6.
3
Stem cell research in the Greater Middle East: the importance of establishing policy and ethics interoperability to foster international collaborations.
Stem Cell Rev Rep. 2010 Jun;6(2):143-50. doi: 10.1007/s12015-010-9133-6.
本文引用的文献
1
Assuring the safety of genetically modified (GM) foods: the importance of an holistic, integrative approach.
J Biotechnol. 2002 Sep 11;98(1):79-106. doi: 10.1016/s0168-1656(02)00088-3.
2
Safety assessment and public concern for genetically modified food products: the European view.
Toxicol Pathol. 2002 Jan-Feb;30(1):129-31. doi: 10.1080/01926230252824824.
3
Islamic viewpoint of organ transplantation.
Transplant Proc. 1999 Dec;31(8):3271-4. doi: 10.1016/s0041-1345(99)00721-6.
4
In vitro fertilization and embryo transfer in Egypt.
Int J Gynaecol Obstet. 1991 Sep;36(1):49-53. doi: 10.1016/0020-7292(91)90178-8.
Zotero 插件